Compositions comprising drospirenone molecularly dispersed

Details for Australian Patent Application No. 2005221402 (hide)

Owner Bayer Schering Pharma Aktiengesellschaft

Inventors Funke, Adrian; Wagner, Torsten

Agent Davies Collison Cave

Pub. Number AU-B-2005221402

PCT Pub. Number WO2005/087194

Priority 04075713.0 10.03.04 EP; 60/551,355 10.03.04 US

Filing date 10 March 2005

Wipo publication date 22 September 2005

Acceptance publication date 17 December 2009

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/107 (2006.01) Medicinal preparations characterised by special physical form - Emulsions

A61K 9/14 (2006.01) Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 9/48 (2006.01) Medicinal preparations characterised by special physical form - Preparations in capsules, e.g. of gelatin, of chocolate

A61K 9/70 (2006.01) Medicinal preparations characterised by special physical form - Web, sheet or filament bases

A61K 31/565 (2006.01) - not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol

Event Publications

2 November 2006 PCT application entered the National Phase

  PCT publication WO2005/087194 Priority application(s): WO2005/087194

1 October 2009 Alteration of Name

  The name of the applicant has been altered to Bayer Schering Pharma Aktiengesellschaft

17 December 2009 Application Accepted

  Published as AU-B-2005221402

15 April 2010 Standard Patent Sealed

6 October 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005221403-Stabilised supersaturated solids of lipophilic drugs

2005221401-C1-symmetric bisphosphine ligands and their use in the asymmetric synthesis of pregabalin